MUC1 and cancer: The overexpression of MUC1 in cancers and its association with poor prognosis in cancer patients led us to investigate a potential role of this oncoprotein in cancer progression.19, 20 Using a combination of loss- and gain-of function approach, we provided both in vitro and in vivo evidence directly linking MUC1 to acquired chemoresistance.